ReShape Lifesciences receives Nasdaq delisting notice; intends to appeal

Vyome Holdings, Inc

Nasdaq determined to delist RSLS for failing to meet $2.5M stockholders' equity requirement by May 27, 2025 extension deadline.
Trading will be suspended June 6 unless the company appeals by June 4; a Form 25-NSE will then remove securities from listing.
Company intends to appeal to a Nasdaq hearings panel, which would stay suspension pending decision.
No assurance hearings panel will grant continued listing or that compliance with listing rules can be maintained.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.